CVS Q1 adjusted EPS hit $2.25, topping expectations.
Aetna Medicare Advantage saw improved star ratings and performance.
CVS Caremark offers Wegovy with lifestyle support from July 2025.
Retail pharmacy sales lagged due to weaker consumer demand.
CVS faces legal hit from Omnicare verdict—$431M charge taken.
CVS continues restructuring and cost cuts as part of turnaround plan.
Health Services revenue grew to $43.46B—near expectations.
CVS anticipated high medical costs, avoiding earnings surprises
Learn more